Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 12, Issue 3

2020 March - 246 articles

Cover Story: Breast cancer (BC) is the most common cancer in women worldwide. Approximately 70–80% of BCs express estrogen receptors (ER) and are, therefore, hormone receptor-positive (HR+). Endogenous cannabinoids together with cannabinoid receptor 1 and 2 (CB1, CB2) constitute the basis of the endocannabinoid system and interactions of cannabinoids with hypothalamic-pituitary-gonadal axis hormones are well documented. Do cannabinoids have an effect on HR+ BC? In most preclinical studies, CB1 and CB2 agonists (i.e., anandamide, THC) have been shown to inhibit the proliferation of ER-positive BC cell lines. There is less evidence for antitumor cannabinoid action in HR+ BC in animal models and no clinical trials are exploring the effects of cannabinoids on HR+ BC treatment outcomes. In this paper, we review known and possible interactions between cannabinoids and specific HR+ BC treatments. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (246)

  • Article
  • Open Access
42 Citations
4,753 Views
11 Pages

24 March 2020

Identifying MRI-based radiomics features capable to assess response to systemic treatment in multiple myeloma (MM) patients. Retrospective analysis of whole-body MR-image data in 67 consecutive stage III MM patients (40 men; mean age, 60.4 years). Bo...

  • Article
  • Open Access
12 Citations
3,612 Views
15 Pages

Proposed Modification of Staging for Distal Cholangiocarcinoma Based on the Lymph Node Ratio Using Korean Multicenter Database

  • Yunghun You,
  • Yong Chan Shin,
  • Dong Wook Choi,
  • Jin Seok Heo,
  • Sang Hyun Shin,
  • Naru Kim,
  • Kee-Taek Jang,
  • Hongbeom Kim,
  • Chang-Sup Lim and
  • In Woong Han
  • + 2 authors

24 March 2020

The 8th American Joint Committee on Cancer (AJCC) staging system for distal cholangiocarcinoma (DCC) included a positive lymph node count (PLNC), but a comparison of the prognostic predictive power of PLNC and lymph node ratio (LNR) is still under de...

  • Article
  • Open Access
33 Citations
4,957 Views
12 Pages

Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype

  • Veronika Weyerer,
  • Markus Eckstein,
  • Eva Compérat,
  • Hendrik Juette,
  • Nadine T. Gaisa,
  • Yves Allory,
  • Robert Stöhr,
  • Bernd Wullich,
  • Morgan Rouprêt and
  • Simone Bertz
  • + 1 author

24 March 2020

Since 2016, large nested urothelial carcinoma (LNUC) has been included within the WHO classification of urothelial tumors. Limited reports with mainly small case series have confirmed the malignant behavior of LNUC despite its bland morphological app...

  • Article
  • Open Access
58 Citations
8,485 Views
25 Pages

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability

  • Wa Zhang,
  • David Klinkebiel,
  • Carter J. Barger,
  • Sanjit Pandey,
  • Chittibabu Guda,
  • Austin Miller,
  • Stacey N. Akers,
  • Kunle Odunsi and
  • Adam R. Karpf

24 March 2020

A hallmark of human cancer is global DNA hypomethylation (GDHO), but the mechanisms accounting for this defect and its pathological consequences have not been investigated in human epithelial ovarian cancer (EOC). In EOC, GDHO was associated with adv...

  • Review
  • Open Access
40 Citations
9,948 Views
17 Pages

24 March 2020

Nonsense-mediated messenger RNA (mRNA) decay (NMD) is a surveillance pathway used by cells to control the quality mRNAs and to fine-tune transcript abundance. NMD plays an important role in cell cycle regulation, cell viability, DNA damage response,...

  • Perspective
  • Open Access
4 Citations
6,251 Views
23 Pages

Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes

  • Yonghyo Kim,
  • Jeovanis Gil,
  • Indira Pla,
  • Aniel Sanchez,
  • Lazaro Hiram Betancourt,
  • Boram Lee,
  • Roger Appelqvist,
  • Christian Ingvar,
  • Lotta Lundgren and
  • György Marko-Varga
  • + 10 authors

24 March 2020

Malignant melanoma is among the most aggressive skin cancers and it has among the highest metastatic potentials. Although surgery to remove the primary tumor is the gold standard treatment, once melanoma progresses and metastasizes to the lymph nodes...

  • Article
  • Open Access
27 Citations
5,585 Views
14 Pages

30 Years of Experience in the Management of Stage III and IV Epithelial Ovarian Cancer: Impact of Surgical Strategies on Survival

  • Berenice Delga,
  • Jean-Marc Classe,
  • Gilles Houvenaeghel,
  • Guillaume Blache,
  • Laura Sabiani,
  • Houssein El Hajj,
  • Nicole Andrieux and
  • Eric Lambaudie

24 March 2020

Objective: to analyze the evolution of surgical techniques and strategies, and to determine their influence on the survival of patients with stage III or IV epithelial ovarian cancer (EOC). Methods: a retrospective data analysis was performed in two...

  • Article
  • Open Access
24 Citations
5,871 Views
22 Pages

Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment

  • Whitney N. Goldsberry,
  • Selene Meza-Perez,
  • Angelina I. Londoño,
  • Ashwini A. Katre,
  • Bryan T. Mott,
  • Brandon M. Roane,
  • Nidhi Goel,
  • Jaclyn A. Wall,
  • Sara J. Cooper and
  • Rebecca C. Arend
  • + 3 authors

24 March 2020

In ovarian cancer, upregulation of the Wnt/β–catenin pathway leads to chemoresistance and correlates with T cell exclusion from the tumor microenvironment (TME). Our objectives were to validate these findings in an independent cohort of ov...

  • Article
  • Open Access
14 Citations
6,051 Views
18 Pages

Accessing a New Dimension in TP53 Biology: Multiplex Long Amplicon Digital PCR to Specifically Detect and Quantitate Individual TP53 Transcripts

  • Annette Lasham,
  • Peter Tsai,
  • Sandra J. Fitzgerald,
  • Sunali Y. Mehta,
  • Nicholas S. Knowlton,
  • Antony W. Braithwaite and
  • Cristin G. Print

24 March 2020

TP53, the most commonly-mutated gene in cancer, undergoes complex alternative splicing. Different TP53 transcripts play different biological roles, both in normal function and in the progression of diseases such as cancer. The study of TP53’s a...

  • Review
  • Open Access
21 Citations
5,300 Views
27 Pages

The Regulatory Functions of Circular RNAs in Digestive System Cancers

  • Xiao Yuan,
  • Ya Yuan,
  • Zhi He,
  • Diyan Li,
  • Bo Zeng,
  • Qingyong Ni,
  • Mingyao Yang and
  • Deying Yang

24 March 2020

Circular ribonucleic acids (circRNAs), which are a type of covalently closed circular RNA, are receiving increasing attention. An increasing amount of evidence suggests that circRNAs are involved in the biogenesis and development of multiple diseases...

  • Article
  • Open Access
21 Citations
5,043 Views
12 Pages

Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis

  • Aya Takahashi,
  • Michihisa Moriguchi,
  • Yuya Seko,
  • Toshihide Shima,
  • Yasuhide Mitsumoto,
  • Hidetaka Takashima,
  • Hiroyuki Kimura,
  • Hideki Fujii,
  • Hiroki Ishikawa and
  • Yoshito Itoh
  • + 16 authors

23 March 2020

We investigated the association between early tumor shrinkage (ETS) and treatment outcome in patients with hepatocellular carcinoma treated with lenvatinib (LEN). A retrospective analysis was performed in 104 patients. ETS was defined as tumor shrink...

  • Article
  • Open Access
12 Citations
5,182 Views
17 Pages

Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma

  • Lovely Raghav,
  • Ya-Hsuan Chang,
  • Yi-Chiung Hsu,
  • Yu-Cheng Li,
  • Chih-Yi Chen,
  • Tsung-Ying Yang,
  • Kun-Chieh Chen,
  • Kuo-Hsuan Hsu,
  • Jeng-Sen Tseng and
  • Hsuan-Yu Chen
  • + 12 authors

23 March 2020

Risk factors including genetic effects are still being investigated in lung adenocarcinoma (LUAD). Mitochondria play an important role in controlling imperative cellular parameters, and anomalies in mitochondrial function might be crucial for cancer...

  • Article
  • Open Access
29 Citations
6,311 Views
25 Pages

Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid

  • Mariah M. Hoffman,
  • Jessica S. Zylla,
  • Somshuvra Bhattacharya,
  • Kristin Calar,
  • Timothy W. Hartman,
  • Ratan D. Bhardwaj,
  • W. Keith Miskimins,
  • Pilar de la Puente,
  • Etienne Z. Gnimpieba and
  • Shanta M. Messerli

23 March 2020

Central nervous system atypical teratoid/rhabdoid tumors (ATRTs) are rare and aggressive tumors with a very poor prognosis. Current treatments for ATRT include resection of the tumor, followed by systemic chemotherapy and radiation therapy, which hav...

  • Article
  • Open Access
29 Citations
4,929 Views
18 Pages

23 March 2020

Background: Recurrence and distant organ metastasis is a major cause of death in colorectal cancer (CRC); however, the underlying molecular mechanisms regulating this phenomenon are poorly understood. MeCP2 is a key epigenetic regulator and is amplif...

  • Article
  • Open Access
26 Citations
9,082 Views
9 Pages

LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications

  • Eytan Ben-Ami,
  • Raul Perret,
  • Ying Huang,
  • Félicie Courgeon,
  • Prafulla C. Gokhale,
  • Audrey Laroche-Clary,
  • Benjamin K. Eschle,
  • Valérie Velasco,
  • François Le Loarer and
  • Antoine Italiano
  • + 3 authors

23 March 2020

Background: LRRC15 is a member of the LRR (leucine-rich repeat) superfamily present on tumor-associated fibroblasts (CAFs) and stromal cells. The expression of LRRC15 is upregulated by the pro-inflammatory cytokine TGFβ. ABBV-085 is a monomethyl...

  • Article
  • Open Access
23 Citations
4,114 Views
16 Pages

23 March 2020

New microRNA-based serum biomarkers (miRNA-367-3p, -371a-3p, -372-3p, and -373-3p) have shown great potential for the detection of testicular germ cell tumors (TGCTs), but few studies have investigated the clinical utility and performance of these te...

  • Article
  • Open Access
10 Citations
3,787 Views
18 Pages

CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males

  • Cassy M. Spiller,
  • João Lobo,
  • Willem P. A. Boellaard,
  • Ad J. M. Gillis,
  • Josephine Bowles and
  • Leendert H. J. Looijenga

23 March 2020

miR-371a-3p is currently the most informative reported biomarker for germ cell tumors (GCTs). Another developmental-related biomarker, CRIPTO, is involved in the regulation of pluripotency and germ cell fate commitment. We aimed to assess the value o...

  • Review
  • Open Access
48 Citations
9,193 Views
16 Pages

Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer

  • Manuel Regouc,
  • Gazanfer Belge,
  • Anja Lorch,
  • Klaus-Peter Dieckmann and
  • Martin Pichler

22 March 2020

Testicular cancer is an important disease with increasing incidence and a high burden of morbidity and mortality in young men worldwide. Histological examination of the testicular tissue after orchiectomy plays an important role alongside patient his...

  • Article
  • Open Access
31 Citations
4,914 Views
15 Pages

Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth

  • Husain Yar Khan,
  • Gabriel B. Mpilla,
  • Rachel Sexton,
  • Srikant Viswanadha,
  • Kumar V. Penmetsa,
  • Amro Aboukameel,
  • Maria Diab,
  • Mandana Kamgar,
  • Mohammed Najeeb Al-Hallak and
  • Asfar S. Azmi
  • + 5 authors

22 March 2020

Pancreatic ductal adenocarcinoma (PDAC) remains an unmet clinical problem in urgent need of newer molecularly driven treatment modalities. Calcium signals, particularly those associated with calcium release-activated calcium (CRAC) channels, are know...

  • Perspective
  • Open Access
82 Citations
7,315 Views
20 Pages

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives

  • Bas Weenink,
  • Pim J. French,
  • Peter A.E. Sillevis Smitt,
  • Reno Debets and
  • Marjolein Geurts

22 March 2020

Glioblastomas are aggressive, fast-growing primary brain tumors. After standard-of-care treatment with radiation in combination with temozolomide, the overall prognosis of newly diagnosed patients remains poor, with a 2-year survival rate of less tha...

  • Article
  • Open Access
12 Citations
6,270 Views
20 Pages

Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors

  • Huy Minh Tran,
  • Kuo-Sheng Wu,
  • Shian-Ying Sung,
  • Chun Austin Changou,
  • Tsung-Han Hsieh,
  • Yun-Ru Liu,
  • Yen-Lin Liu,
  • Min-Lan Tsai,
  • Hsin-Lun Lee and
  • Tai-Tong Wong
  • + 14 authors

22 March 2020

Atypical teratoid rhabdoid tumors (ATRTs) are among the most malignant brain tumors in early childhood and remain incurable. Myc-ATRT is driven by the Myc oncogene, which directly controls the intracellular protein synthesis rate. Proteasome inhibito...

  • Article
  • Open Access
27 Citations
7,371 Views
18 Pages

Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer

  • Kimi Drobin,
  • Michal Marczyk,
  • Martin Halle,
  • Daniel Danielsson,
  • Anna Papiez,
  • Traimate Sangsuwan,
  • Annika Bendes,
  • Mun-Gwan Hong,
  • Ulrika Qundos and
  • Siamak Haghdoost
  • + 4 authors

22 March 2020

Nearly half of all cancers are treated with radiotherapy alone or in combination with other treatments, where damage to normal tissues is a limiting factor for the treatment. Radiotherapy-induced adverse health effects, mostly of importance for cance...

  • Article
  • Open Access
3 Citations
3,637 Views
15 Pages

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody

  • Chiara Modica,
  • Simona Gallo,
  • Cristina Chiriaco,
  • Martina Spilinga,
  • Paolo Maria Comoglio,
  • Tiziana Crepaldi,
  • Cristina Basilico and
  • Elisa Vigna

21 March 2020

The MET oncogene encodes a tyrosine kinase receptor involved in the control of a complex network of biological responses that include protection from apoptosis and stimulation of cell growth during embryogenesis, tissue regeneration, and cancer progr...

  • Article
  • Open Access
57 Citations
6,411 Views
13 Pages

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response

  • Rita Cabrita,
  • Shamik Mitra,
  • Adriana Sanna,
  • Henrik Ekedahl,
  • Kristina Lövgren,
  • Håkan Olsson,
  • Christian Ingvar,
  • Karolin Isaksson,
  • Martin Lauss and
  • Göran Jönsson
  • + 1 author

21 March 2020

Checkpoint blockade therapies have changed the clinical management of metastatic melanoma patients considerably, showing survival benefits. Despite the clinical success, not all patients respond to treatment or they develop resistance. Although there...

  • Review
  • Open Access
18 Citations
5,304 Views
20 Pages

Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)

  • Trevor J. Mathias,
  • Katarina T. Chang,
  • Stuart S. Martin and
  • Michele I. Vitolo

21 March 2020

The metastatic cascade consists of multiple complex steps, but the belief that it is a linear process is diminishing. In order to metastasize, cells must enter the blood vessels or body cavities (depending on the cancer type) via active or passive me...

  • Article
  • Open Access
29 Citations
13,881 Views
21 Pages

Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety

  • Yanming Wang,
  • Lianqi Liu,
  • Shiyong Fan,
  • Dian Xiao,
  • Fei Xie,
  • Wei Li,
  • Wu Zhong and
  • Xinbo Zhou

21 March 2020

Monomethyl auristatin E (MMAE) is the most popular and widely used cytotoxin in the development of antibody-drug conjugates (ADCs). However, current MMAE-based ADCs are all constructed using cleavable linkers, and this design concept still has insurm...

  • Article
  • Open Access
33 Citations
5,421 Views
16 Pages

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy

  • Sooyeon Oh,
  • YoungJoon Park,
  • Hyun-Jung Lee,
  • Jooho Lee,
  • Soo-Hyeon Lee,
  • Young-Seok Baek,
  • Su-Kyung Chun,
  • Seung-Min Lee,
  • Mina Kim and
  • KyuBum Kwack
  • + 5 authors

21 March 2020

The chemotherapeutics sorafenib and regorafenib inhibit shedding of MHC class I-related chain A (MICA) from hepatocellular carcinoma (HCC) cells by suppressing a disintegrin and metalloprotease 9 (ADAM9). MICA is a ligand for natural killer (NK) grou...

  • Article
  • Open Access
9 Citations
4,221 Views
14 Pages

Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients

  • Giorgia Mandili,
  • Laura Follia,
  • Giulio Ferrero,
  • Hiroyuki Katayama,
  • Wang Hong,
  • Amin A. Momin,
  • Michela Capello,
  • Daniele Giordano,
  • Rosella Spadi and
  • Francesco Novelli
  • + 4 authors

21 March 2020

Pancreatic Ductal Adenocarcinoma (PDA) is an aggressive malignancy with a very poor outcome. Although chemotherapy (CT) treatment has poor efficacy, it can enhance tumor immunogenicity. Tumor-Associated Antigens (TAA) are self-proteins that are overe...

  • Article
  • Open Access
40 Citations
6,394 Views
10 Pages

Association between Angiotensin-Converting Enzyme Inhibitors and Lung Cancer—A Nationwide, Population-Based, Propensity Score-Matched Cohort Study

  • Shih-Yi Lin,
  • Cheng-Li Lin,
  • Cheng-Chieh Lin,
  • Wu-Huei Hsu,
  • Chia-Der Lin,
  • I.-Kuan Wang,
  • Chung-Y. Hsu and
  • Chia-Hung Kao

21 March 2020

Background: Direct evidence of lung cancer risk in Asian users of angiotensin-converting enzyme inhibitors (ACEIs) is lacking. Methods: The ACEI cohort comprised 22,384 patients aged ≥ 18 years with a first prescription of ACEI. The comparison ang...

  • Article
  • Open Access
23 Citations
5,681 Views
19 Pages

KLF5 Is Crucial for Androgen-AR Signaling to Transactivate Genes and Promote Cell Proliferation in Prostate Cancer Cells

  • Juan Li,
  • Baotong Zhang,
  • Mingcheng Liu,
  • Xing Fu,
  • Xinpei Ci,
  • Jun A,
  • Changying Fu,
  • Ge Dong,
  • Rui Wu and
  • Jin-Tang Dong
  • + 2 authors

21 March 2020

Androgen/androgen receptor (AR) signaling drives both the normal prostate development and prostatic carcinogenesis, and patients with advanced prostate cancer often develop resistance to androgen deprivation therapy. The transcription factor Krü...

  • Article
  • Open Access
24 Citations
4,752 Views
12 Pages

Gastrointestinal Stromal Tumours (GIST) in Young Adult (18–40 Years) Patients: A Report from the Dutch GIST Registry

  • Nikki S. IJzerman,
  • Cas Drabbe,
  • Dide den Hollander,
  • Mahmoud Mohammadi,
  • Hester van Boven,
  • Ingrid M.E. Desar,
  • Hans Gelderblom,
  • Dirk J. Grünhagen,
  • An K.L. Reyners and
  • Winette T.A. van der Graaf
  • + 3 authors

20 March 2020

Gastrointestinal stromal tumour (GIST) is a disease of older adults and is dominated by KIT/PDGFR mutations. In children, GIST is rare, predominantly occurs in girls, has a stomach location and generally lacks KIT/PDGFR mutations. For young adults (Y...

  • Review
  • Open Access
392 Citations
27,075 Views
17 Pages

Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy

  • Charles Pottier,
  • Margaux Fresnais,
  • Marie Gilon,
  • Guy Jérusalem,
  • Rémi Longuespée and
  • Nor Eddine Sounni

20 March 2020

Receptor tyrosine kinases (RTKs) are key regulatory signaling proteins governing cancer cell growth and metastasis. During the last two decades, several molecules targeting RTKs were used in oncology as a first or second line therapy in different typ...

  • Review
  • Open Access
47 Citations
7,363 Views
20 Pages

20 March 2020

For the treatment of early and locally advanced glottic laryngeal cancer, multiple strategies are available. These are pursued and supported by different levels of evidence, but also by national and institutional traditions. The purpose of this revie...

  • Review
  • Open Access
26 Citations
5,936 Views
17 Pages

Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review

  • Burcin Özdirik,
  • Antonin Kayser,
  • Andrea Ullrich,
  • Lynn J. Savic,
  • Markus Reiss,
  • Frank Tacke,
  • Bertram Wiedenmann,
  • Henning Jann and
  • Christoph Roderburg

20 March 2020

Primary neuroendocrine carcinoma of the breast (NECB) as defined by the World Health Organization (WHO) in 2012 is a rare, but possibly under-diagnosed entity. It is heterogeneous as it entails a wide spectrum of diseases comprising both well-differe...

  • Article
  • Open Access
47 Citations
5,043 Views
16 Pages

Extracellular Vesicle lincRNA-p21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior

  • Joan J. Castellano,
  • Ramon M. Marrades,
  • Laureano Molins,
  • Nuria Viñolas,
  • Jorge Moises,
  • Jordi Canals,
  • Bing Han,
  • Yan Li,
  • Daniel Martinez and
  • Alfons Navarro
  • + 1 author

20 March 2020

Hypoxia-induced upregulation of lincRNA-p21 in tumor tissue was previously shown by our group to be related to poor prognosis in resected non-small cell lung cancer (NSCLC) patients. In the present study, we have evaluated the presence of lincRNA-p21...

  • Review
  • Open Access
106 Citations
10,701 Views
27 Pages

20 March 2020

Glioblastoma (GBM) is a grade IV glioma that is the most malignant brain tumor type. Currently, there are no effective and sufficient therapeutic strategies for its treatment because its pathological mechanism is not fully characterized. With the fas...

  • Article
  • Open Access
9 Citations
4,457 Views
20 Pages

Recognition Dynamics of Cancer Mutations on the ERp57-Tapasin Interface

  • Monikaben Padariya,
  • Umesh Kalathiya,
  • Douglas R. Houston and
  • Javier Antonio Alfaro

20 March 2020

Down regulation of the major histocompatibility class (MHC) I pathway plays an important role in tumour development, and can be achieved by suppression of HLA expression or mutations in the MHC peptide-binding pocket. The peptide-loading complex (PLC...

  • Review
  • Open Access
1,016 Citations
33,396 Views
19 Pages

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence

  • Raju K. Vaddepally,
  • Prakash Kharel,
  • Ramesh Pandey,
  • Rohan Garje and
  • Abhinav B. Chandra

20 March 2020

Cancer is associated with higher morbidity and mortality and is the second leading cause of death in the US. Further, in some nations, cancer has overtaken heart disease as the leading cause of mortality. Identification of molecular mechanisms by whi...

  • Review
  • Open Access
47 Citations
7,504 Views
26 Pages

The Multifactorial Role of PARP-1 in Tumor Microenvironment

  • Juan Manuel Martí,
  • Mónica Fernández-Cortés,
  • Santiago Serrano-Sáenz,
  • Esteban Zamudio-Martinez,
  • Daniel Delgado-Bellido,
  • Angel Garcia-Diaz and
  • Francisco Javier Oliver

20 March 2020

Poly(ADP-ribose) polymerases (PARPs), represent a family of 17 proteins implicated in a variety of cell functions; some of them possess the enzymatic ability to synthesize and attach poly (ADP-ribose) (also known as PAR) to different protein substrat...

  • Article
  • Open Access
38 Citations
4,836 Views
13 Pages

Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma

  • Soraya Puglisi,
  • Anna Calabrese,
  • Vittoria Basile,
  • Filippo Ceccato,
  • Carla Scaroni,
  • Barbara Altieri,
  • Silvia Della Casa,
  • Paola Loli,
  • Rosario Pivonello and
  • Massimo Terzolo
  • + 12 authors

20 March 2020

Mitotane is the main option of treatment for advanced adrenocortical carcinoma (ACC). However, limited evidence is available regarding the impact of plasma mitotane levels on patient outcome. To address this question, we retrospectively analyzed pati...

  • Article
  • Open Access
21 Citations
5,877 Views
13 Pages

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer

  • Todd M. Pitts,
  • Dennis M. Simmons,
  • Stacey M. Bagby,
  • Sarah J. Hartman,
  • Betelehem W. Yacob,
  • Brian Gittleman,
  • John J. Tentler,
  • Diana Cittelly,
  • D. Ryan Ormond and
  • Jennifer R. Diamond
  • + 2 authors

19 March 2020

Triple-negative breast cancer (TNBC) is an aggressive subtype defined by lack of hormone receptor expression and non-amplified HER2. Adavosertib (AZD1775) is a potent, small-molecule, ATP-competitive inhibitor of the Wee1 kinase that potentiates the...

  • Review
  • Open Access
34 Citations
5,704 Views
20 Pages

Liver Transplantation for Pediatric Liver Cancer

  • Rakesh Sindhi,
  • Vinayak Rohan,
  • Andrew Bukowinski,
  • Sameh Tadros,
  • Jean de Ville de Goyet,
  • Louis Rapkin and
  • Sarangarajan Ranganathan

19 March 2020

Unresectable hepatocellular carcinoma (HCC) was first removed successfully with total hepatectomy and liver transplantation (LT) in a child over five decades ago. Since then, children with unresectable liver cancer have benefitted greatly from LT and...

  • Article
  • Open Access
14 Citations
3,454 Views
21 Pages

Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That is Globally Shared with Invasive Basal-Like Breast Cancer

  • Zhenlin Ju,
  • Anjana Bhardwaj,
  • Matthew D. Embury,
  • Harpreet Singh,
  • Preethi H. Gunaratne,
  • Isabelle Bedrosian and
  • Jing Wang

19 March 2020

To characterize molecular changes accompanying the stepwise progression to breast cancer and to identify functional target pathways, we performed miRNA and RNA sequencing using MCF10A cell lines based model system that replicates the multi-step progr...

  • Article
  • Open Access
56 Citations
4,899 Views
15 Pages

19 March 2020

Cold atmospheric plasma-exposed culture medium may efficiently kill cancer cells in vitro. Due to the complexity of the medium obtained after plasma exposure, less complex physiological liquids, such as saline solutions and saline buffers, are gather...

  • Article
  • Open Access
17 Citations
4,764 Views
27 Pages

Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation

  • Rocco Sciarrillo,
  • Anna Wojtuszkiewicz,
  • Irsan E. Kooi,
  • Leticia G. Leon,
  • Edwin Sonneveld,
  • Roland P. Kuiper,
  • Gerrit Jansen,
  • Elisa Giovannetti,
  • Gertjan J.L. Kaspers and
  • Jacqueline Cloos

19 March 2020

Glucocorticoid (GC) resistance is a crucial determinant of inferior response to chemotherapy in pediatric acute lymphoblastic leukemia (ALL); however, molecular mechanisms underlying this phenomenon are poorly understood. Deregulated splicing is a co...

  • Article
  • Open Access
20 Citations
3,150 Views
11 Pages

Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer

  • Maurine Oreglia,
  • Silviu Sbiera,
  • Martin Fassnacht,
  • Laurent Guyon,
  • Josiane Denis,
  • Justine Cristante,
  • Olivier Chabre and
  • Nadia Cherradi

19 March 2020

We have previously identified serum miR-483-5p as a preoperative diagnosis and prognosis biomarker for adrenocortical cancer (ACC). Here, we aimed to determine whether circulating miR-483-5p levels measured 3 months post-operatively distinguished pat...

  • Article
  • Open Access
41 Citations
7,019 Views
24 Pages

Sea Hare Hydrolysate-Induced Reduction of Human Non-Small Cell Lung Cancer Cell Growth through Regulation of Macrophage Polarization and Non-Apoptotic Regulated Cell Death Pathways

  • Marie Merci Nyiramana,
  • Soo Buem Cho,
  • Eun-Jin Kim,
  • Min Jun Kim,
  • Ji Hyeon Ryu,
  • Hyun Jae Nam,
  • Nam-Gil Kim,
  • Si-Hyang Park,
  • Yeung Joon Choi and
  • Dawon Kang
  • + 5 authors

19 March 2020

Sea hare-derived compounds induce macrophage activation and reduce asthmatic parameters in mouse models of allergic asthma. These findings led us to study the role of sea hare hydrolysates (SHH) in cancer pathophysiology. SHH treatment-induced M1 mac...

  • Article
  • Open Access
10 Citations
4,587 Views
16 Pages

Functional Blockade of E-Selectin in Tumor-Associated Vessels Enhances Anti-Tumor Effect of Doxorubicin in Breast Cancer

  • Yoshihiro Morita,
  • Macall Leslie,
  • Hiroyasu Kameyama,
  • Ganesh L. R. Lokesh,
  • Norihisa Ichimura,
  • Rachel Davis,
  • Natalie Chakraborty,
  • Nafis Hasan,
  • Roy Zhang and
  • Takemi Tanaka
  • + 5 authors

19 March 2020

Chemotherapy is a mainstay of treatment for solid tumors. However, little is known about how therapy-induced immune cell infiltration may affect therapy response. We found substantial CD45+ immune cell density adjacent to E-selectin expressing inflam...

  • Article
  • Open Access
78 Citations
8,881 Views
16 Pages

The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells

  • Dong Young Kang,
  • Nipin Sp,
  • Eun Seong Jo,
  • Alexis Rugamba,
  • Dae Young Hong,
  • Hong Ghi Lee,
  • Ji-Seung Yoo,
  • Qing Liu,
  • Kyoung-Jin Jang and
  • Young Mok Yang

19 March 2020

Non-small-cell lung cancer (NSCLC) is the most common lung cancer subtype and accounts for more than 80% of all lung cancer cases. Epidermal growth factor receptor (EGFR) phosphorylation by binding growth factors such as EGF activates downstream proo...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694